Michael J Bishop1, J T O'Donnell, J R Salemi
1*Department of Anesthesiology, University of Washington, Seattle, Washington; †Department of Pharmacology, Rush Medical College, Chicago; and ‡Pharmaconsultant, Inc., Palatine, Illinois.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Severe bronchospasm is a risk with nondepolarizing muscle relaxants. This study analyzed the Food and Drug Administration MedWatch database to assess the frequency of this adverse event.
Area of Science:
Background:
Observation:
Findings:
Implications: